Prognostic Impact of Atrial Rhythm and Dimension in Patients with Structural Heart Disease Undergoing Cardiac Sympathetic Denervation for Ventricular Arrhythmias.

[1]  R. H. Rho,et al.  Electrophysiologic effects and outcomes of sympatholysis in patients with recurrent ventricular arrhythmia and structural heart disease , 2019, Journal of cardiovascular electrophysiology.

[2]  W. Stevenson,et al.  Predictive Score for Identifying Survival and Recurrence Risk Profiles in Patients Undergoing Ventricular Tachycardia Ablation: The I-VT Score , 2018, Circulation. Arrhythmia and electrophysiology.

[3]  Paari Dominic,et al.  Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter‐Defibrillator: A Systematic Review and Meta‐Analysis , 2018, Journal of the American Heart Association.

[4]  Charless C. Fowlkes,et al.  Identification of peripheral neural circuits that regulate heart rate using optogenetic and viral vector strategies , 2018, Nature Communications.

[5]  Michael J Ackerman,et al.  2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2018, Journal of the American College of Cardiology.

[6]  N. Khanlou,et al.  Inflammation, oxidative stress, and glial cell activation characterize stellate ganglia from humans with electrical storm. , 2017, JCI insight.

[7]  Marmar Vaseghi,et al.  Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias. , 2017, Journal of the American College of Cardiology.

[8]  J. Lekakis,et al.  Acute effects of unilateral temporary stellate ganglion block on human atrial electrophysiological properties and atrial fibrillation inducibility. , 2016, Heart rhythm.

[9]  S. Khalsa,et al.  Clinical neurocardiology defining the value of neuroscience‐based cardiovascular therapeutics , 2016, The Journal of physiology.

[10]  D. O'Leary,et al.  Translational neurocardiology: preclinical models and cardioneural integrative aspects , 2016, The Journal of physiology.

[11]  M. Ackerman,et al.  Quality of life after videoscopic left cardiac sympathetic denervation in patients with potentially life-threatening cardiac channelopathies/cardiomyopathies. , 2016, Heart rhythm.

[12]  M. Mack,et al.  Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. , 2015, Journal of the American College of Cardiology.

[13]  A. Mahajan,et al.  Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. , 2014, Heart rhythm.

[14]  B. Hoit,et al.  Left atrial size and function: role in prognosis. , 2014, Journal of the American College of Cardiology.

[15]  P. Collinson,et al.  Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: Implication for diagnosis of diastolic heart failure , 2006, European journal of heart failure.

[16]  H. L. Stone,et al.  Effects of Unilateral Stellectomy upon Cardiac Performance during Exercise in Dogs , 1979, Circulation research.

[17]  M. C. Rogers,et al.  Lateralization of sympathetic control of the human sinus node: ECG changes of stellate ganglion block. , 1978, Anesthesiology.